Objectives: To explore community pharmacies' experience with two models of distribution for publicly-funded influenza vaccines in Ontario, Canada-one being publicly-managed (2015-2016 influenza season) and one involving private pharmaceutical distributors (2016-2017 season).
Methods: Online surveys were distributed to community pharmacies across Ontario during the 2015-2016 and 2016-2017 influenza seasons with sampling proportional to Ontario Public Health Unit catchment populations. Quantitative data were analyzed descriptively and inferentially and qualitative data were summarized for additional context.
Results: Order fulfillment appeared more responsive with the addition of private distributors in 2016-2017, as more pharmacies reported shorter order fulfillment times ( < 0.01); however, pharmacies reported significantly more days with zero on-hand inventory in 2016-2017 ( < 0.01), as well as more instances of patients being turned away due to vaccine unavailability ( < 0.05). In both seasons, a similar proportion of pharmacies reported slower order fulfillment and limited order quantities early in the season. Improved availability early in the season when patient demand is highest, more vaccines in a pre-filled syringe format, and better communication from distributors on product availability dates were recommended in qualitative responses.
Conclusions: Introducing private distributors for the management and fulfillment of pharmacies' orders for the publicly funded influenza vaccine appeared to have mixed results. While key concerns surrounding the frequency, responsiveness, and method of delivery were addressed by this change, challenges remain-in particular, acquiring sufficient vaccine early in the season to meet patient demand. As pharmacies become more prominent as vaccination sites, there are several opportunities to ensure that patient demand is met in this setting.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167743 | PMC |
http://dx.doi.org/10.3390/pharmacy9020094 | DOI Listing |
Dysphagia
December 2024
University of Canterbury Rose Centre for Stroke Recovery and Research, St George's Medical Centre, Level One, Leinster Chambers, 249 Papanui Road, Merivale, Christchurch, 8014, New Zealand.
Front Microbiol
November 2024
Pathology and Mycotoxin Unit, IITA, Ibadan, Nigeria.
Front Med (Lausanne)
November 2024
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Background: The pharmaceutical promotion is "all informational and persuasive activities by manufacturers and distributors, the effect of which is to induce the prescription, supply, purchase and/or use of medicinal drugs. These promotional activities affect the dispensing behavior of physicians and pharmacists and influence begins from educational institutes.
Objective: Our study's main aim was to evaluate opinion and attitude of pharmacy students towards pharmaceutical promotion.
J Immunol Res
November 2024
SANNA el Golf Clinic, Lima, Peru.
Eur J Health Econ
September 2024
Department of Health Policy and Medical Technology Research Group-LSE Health, The London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK.
This paper analyses the structure of and variability in taxation and prescription drug distribution policies and quantifies the impact of such policies on the cost of prescription drugs to health systems in 35 countries. Taxes on prescription drugs remain highly prevalent (83% of the sample) although 63% of the sample countries implement a lower than standard VAT rate. Three remuneration types of the wholesale and retail distribution chain have been identified.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!